Glen T. Schumock
Dean, College of Pharmacy
Professor, College of Pharmacy - Pharmacy Systems, Outcomes and Policy
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
Dean’s Leadership Forum (PMPR 329), 8/22/2022 – 12/2/2022
Dean’s Leadership Forum (PMPR 329), 8/22/2022 – 12/2/2022
Ph.D. Thesis Research (PSOP 599), 1/10/2022 – 4/29/2022
Ph.D. Thesis Research (PSOP 599), 8/23/2021 – 12/3/2021
Ph.D. Thesis Research (PSOP 599), 1/11/2021 – 4/30/2021
Ph.D. Thesis Research (PSOP 599), 8/28/2017 – 12/8/2017
Pharm Services & Reimbursement (PHAR 346), 8/28/2017 – 12/8/2017
Pharm Services & Reimbursement (PHAR 346), 8/28/2017 – 12/8/2017
Res in Pharm Syst Outcomes Pol (PSOP 380), 8/28/2017 – 12/8/2017
Selected Grants
Risk of Venous Thromboembolism Following Diagnosis and Treatment of Multiple Myeloma : differences by race, National Institutes of Health (National Heart, Lung, and Blood Institute)., 1/1/2018 - 12/31/2019, Obligated Amount: $438969; Anticipated Amount: $438969
Second Generation Antipsychotics on Diabetes Outcomes in Major Depression, Funded by National Institutes of Mental Health., 8/8/2017 - 8/7/2018, Obligated Amount: $28044; No Anticipated Amount Set
Medication Safety Systems in the Community: the Role of Pharmacists White Paper, Gordon & Betty Moore Foundation., 6/1/2017 - 12/31/2017, Obligated Amount: $77130; Anticipated Amount: $77130
Institute for Clinical and Economic Review Modeling Studies, Institute for Clinical and Economic Review., 3/16/2017 - 3/15/2018, Obligated Amount: $125000; No Anticipated Amount Set
Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical Research Inc., 3/16/2017 - 12/31/2020, Obligated Amount: $500000; Anticipated Amount: $500000
Anticoagulation Self-Monitoring In Minority Patients, National Institutes of Health (National Heart, Lung, and Blood Institute)., 2/1/2016 - 1/31/2018, Obligated Amount: $132095; Anticipated Amount: $132095
UIC Center of Excellence for Comparative Effectiveness Research Educational Program, PhRMA Fdn., 1/1/2015 - 12/31/2016, Obligated Amount: $250032; Anticipated Amount: $250032
Sentinel Initiative, Food and Drug Administration., 1/1/2015 - 12/31/2020, No Obligated Amount Set; No Anticipated Amount Set
2015 Center of Excellence for Comparative Effectiveness Research (CER) Education., Pharmaceutical Research and Manufacturers Association (PhRMA) Foundation.., 1/1/2015 - 12/31/2017, Obligated Amount: $250000; No Anticipated Amount Set
Selected Publications
Tichy, EM, Hoffman, JM, Suda, KJ, Rim, MH, Tadrous, M, Cuellar, S, Clark, JS, Ward, J, Schumock, GT. (2022). National trends in prescription drug expenditures and projections for 2022. American Journal of Health-System Pharmacy, 79, (14), 1158-1172. doi:10.1093/ajhp/zxac102.
Moran, KM, Calip, GS, Lee, TA, Koronkowski, MJ, Lau, DT, Schumock, GT. (2021). Risk of fall-related injury and all-cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: A case-time-control analysis. Pharmacotherapy, 41, (9), 733-742. doi:10.1002/phar.2612.
Tichy, EM, Hoffman, JM, Suda, KJ, Rim, MH, Tadrous, M, Cuellar, S, Clark, JS, Wiest, MD, Matusiak, LM, Schumock, GT. (2021). National trends in prescription drug expenditures and projections for 2021. American Journal of Health-System Pharmacy, 78, (14), 1294-1308. doi:10.1093/ajhp/zxab160.
Patel, H, DiDomenico, RJ, Suda, KJ, Schumock, GT, Calip, GS, Lee, TA. (2020). Risk of cardiac events with azithromycin—A prediction model. PLoS ONE, 15, (10 October). doi:10.1371/journal.pone.0240379.
Patel, H, Calip, GS, DiDomenico, RJ, Schumock, GT, Suda, KJ, Lee, TA. (2020). Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. JAMA network open, 3, (9), e2016864. doi:10.1001/jamanetworkopen.2020.16864.
Tichy, EM, Schumock, GT, Hoffman, JM, Suda, KJ, Rim, MH, Tadrous, M, Wiest, MD, Matusiak, LM, Clark, JS, Cuellar, S, Stubbings, JA, Vermeulen, LC, Hunkler, RJ. (2020). National trends in prescription drug expenditures and projections for 2020. American Journal of Health-System Pharmacy, 77, (15), 1213-1230. doi:10.1093/ajhp/zxaa116.
Sharma, D, Schumock, GT, Saffore, CD, Albert Edwards, S, Walton, SM. (2020). Estimating the Impact of Food and Drug Administration’s Unapproved Drug Initiative on Drug Prices and Sales. Therapeutic Innovation and Regulatory Science, 54, (2), 424-430. doi:10.1007/s43441-019-00072-8.
Harrington, RL, Qato, DM, Antoon, JW, Caskey, RN, Schumock, GT, Lee, TA. (2020). Impact of multimorbidity subgroups on the health care use of early pediatric cancer survivors. Cancer, 126, (3), 649-658. doi:10.1002/cncr.32201.
Patel, H, Calip, GS, DiDomenico, RJ, Schumock, GT, Suda, KJ, Lee, TA. (2020). Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms. Pharmacotherapy, 40, (2), 107-115. doi:10.1002/phar.2355.
Education
Degrees:
Bachelors of Pharmacy, Washington State University, United States, 1987
Doctor of Pharmacy, School of Pharmacy, University of Washington, United States, 1989
Masters of Business Administration, University of Illinois at Chicago, United States, 1994
Doctor of Philosophy in Public Health Sciences - Pharmacoepidemiology, University of Illinois at Chicago, United States, 2012
Postgraduate Training:
Residency in Hospital Pharmacy, University of Washington Medical Center, United States, 1989
Fellowship in Hospital Pharmacy Administration, University of Illinois at Chicago, United States, 1992
Specialized Residency in Hospital Pharmacy Administration, University of Illinois at Chicago, United States, 1991
Licensures and Certifications
Presidential Executive Leadership Program, University of Illinois System, 1/1/2019 - 12/31/2020
Selected Presentations
Harrington, RL, Qato, DM, Antoon, JW, Caskey, RN, Schumock, GT, Lee, TA. (2019 June 01). Multimorbidity and healthcare utilization among early survivors of pediatric cancer. doi:10.1002/pbc.27655.
Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2018 January 01). SGLT2 inhibitors and mycotic infections: A prescription sequence symmetry analysis.
Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2018 January 01). Risk of amputations associated with SGLT2 inhibitors: A propensity-matched cohort study.